isoxazole ethers and non-benzodiazepine GABA-A alpha5 positive allosteric modulators (Roche)

N/A

Report date: 2025/03/20 15:17:21

NME

Base Information

Drug Nameisoxazole ethers and non-benzodiazepine GABA-A alpha5 positive allosteric modulators (Roche)

Drug Alias NameGABA-A alpha5 PAMs (Roche)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionGamma-aminobutyric acid A receptor alpha-5 modulators

TargetsGamma-aminobutyric acid A receptor alpha-5

Therapy Area/IndicationsNervous System Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesRoche Holding Ltd

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsNervous System Diseases

Inactive IndicationsN/A

ATC CodeN/A